It was truly inspiring to attend the world’s biggest TB conference in India, standing side by side TB survivors, activists and global health experts to call for pharmaceutical corporation Johnson & Johnson (J&J) to lower the price of the lifesaving TB drug, bedaquiline. At the same conference MSF and partners presented on high treatment success rates using bedaquiline for the largest group of people with drug-resistant TB to date.
After our successful Global Day of Action in October kicked off twenty days of protest to mobilise people around the world, we carried the demands of the TB community to the conference to make J&J listen to us.
But J&J was nowhere to be found.
We looked in the halls and corridors, round the back stairs and under the carpets. No show. See how hard we tried!